Author

Enqi Liu

h-index 0 View on Semantic Scholar

We have 1 of 2 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Jul 2026

Mechanism of isorhamnetin in treating triple-negative breast cancer based on network pharmacology, molecular docking, and in vitro verification

The findings revealed that isorhamnetin strongly reduced the growth, motility, and infiltrative capacities of TNBC cells, providing a theoretical basis for its clinical application.

Yanan Hua, Xiangyu Xie, Li Sun et al. · Eurasian Journal of Medicine... · 0 citations